Colinz Laboratories (BOM:531210) COGS-to-Revenue : 0.37 (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories COGS-to-Revenue?

Colinz Laboratories's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹5.97 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹16.30 Mil.

Colinz Laboratories's COGS to Revenue for the three months ended in Mar. 2024 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Colinz Laboratories's Gross Margin % for the three months ended in Mar. 2024 was 63.34%.

Colinz Laboratories COGS-to-Revenue Historical Data

The historical data trend for Colinz Laboratories's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories COGS-to-Revenue Chart

Colinz Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.40

0.37

0.32

0.33

Colinz Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.30	0.33	0.32	0.32	0.37

Colinz Laboratories COGS-to-Revenue Calculation

Colinz Laboratories's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	23.133	/	70.296
	=	0.33

Colinz Laboratories's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	5.973	/	16.295
	=	0.37

Colinz Laboratories (BOM:531210) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Colinz Laboratories's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	5.973 / 16.295
	=	63.34 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Colinz Laboratories COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Colinz Laboratories (BOM:531210) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078

Website

http://www.colinz.com

Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories (BOM:531210) Headlines

No Headlines